BIT 0.00% 2.2¢ biotron limited

hcv trial success, page-5

  1. 346 Posts.
    lightbulb Created with Sketch. 2
    We now know we have synergy in vivo. Tolerability is good which raises the probability of being able to increase increasing the dosage, all in all a very good result IMHO
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.